Viewing Study NCT04592250



Ignite Creation Date: 2024-05-06 @ 3:20 PM
Last Modification Date: 2024-10-26 @ 1:47 PM
Study NCT ID: NCT04592250
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-05-17
First Post: 2020-10-12

Brief Title: Financial Toxicity in Cancer Patients
Sponsor: MD Anderson Cancer Center
Organization: MD Anderson Cancer Center

Study Overview

Official Title: Financial Toxicity in Diverse Cancer Populations and Care Settings
Status: ACTIVE_NOT_RECRUITING
Status Verified Date: 2024-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study will seek to generate the early data needed to understand the relationship between constructs and measures of patients coping resources and psychological response and measures of patients financial toxicity To collect this early descriptive data the overall goal of this study is to identify social behavioral and knowledge factors associated with financial toxicity outcomes Identifying these factors will ultimately help elucidate targets for behavioral psychosocial andor educational and coaching interventions
Detailed Description: PRIMARY OBJECTIVES

1 Examine the associations between measures of self-efficacy quality of social support and financial literacy with the outcome measure of financial toxicity
2 Identify the feasibility of collecting these measures in a Spanish-speaking cancer patient population
3 Describe the relationship between financial toxicity and clinical outcomes survival and disease status This is an exploratory aim
4 a Describe the correlation between measures of self-efficacy quality of social support financial literacy and clinical and demographic patient characteristics with outcome measure of financial toxicity by tumor type and age subgroups b Describe response rate to the financial toxicity measure 50 completed items on the survey instrument by tumor type and age subgroups This is an exploratory aim

OUTLINE

Participants will complete a survey packet that is estimated to take about 30 minutes The survey packet will be collected at baseline and at 6 months

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
2020-0356 OTHER M D Anderson Cancer Center None
NCI-2020-07501 REGISTRY None None